Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 1.59
UTMD's Cash to Debt is ranked higher than
68% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. UTMD: 1.59 )
UTMD' s 10-Year Cash to Debt Range
Min: 0.04   Max: No Debt
Current: 1.59

Equity to Asset 0.75
UTMD's Equity to Asset is ranked higher than
82% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. UTMD: 0.75 )
UTMD' s 10-Year Equity to Asset Range
Min: 0.49   Max: 0.92
Current: 0.75

0.49
0.92
Interest Coverage 33.85
UTMD's Interest Coverage is ranked higher than
73% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.61 vs. UTMD: 33.85 )
UTMD' s 10-Year Interest Coverage Range
Min: 13.79   Max: 9999.99
Current: 33.85

13.79
9999.99
F-Score: 6
Z-Score: 8.19
M-Score: -2.46
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 36.62
UTMD's Operating margin (%) is ranked higher than
98% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.44 vs. UTMD: 36.62 )
UTMD' s 10-Year Operating margin (%) Range
Min: 22.54   Max: 57.84
Current: 36.62

22.54
57.84
Net-margin (%) 28.17
UTMD's Net-margin (%) is ranked higher than
96% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.65 vs. UTMD: 28.17 )
UTMD' s 10-Year Net-margin (%) Range
Min: 17.69   Max: 76.5
Current: 28.17

17.69
76.5
ROE (%) 18.83
UTMD's ROE (%) is ranked higher than
93% of the 283 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. UTMD: 18.83 )
UTMD' s 10-Year ROE (%) Range
Min: 15.91   Max: 56.83
Current: 18.83

15.91
56.83
ROA (%) 14.13
UTMD's ROA (%) is ranked higher than
94% of the 290 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.24 vs. UTMD: 14.13 )
UTMD' s 10-Year ROA (%) Range
Min: 9.71   Max: 41.78
Current: 14.13

9.71
41.78
ROC (Joel Greenblatt) (%) 101.53
UTMD's ROC (Joel Greenblatt) (%) is ranked higher than
97% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.38 vs. UTMD: 101.53 )
UTMD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 25.33   Max: 124.31
Current: 101.53

25.33
124.31
Revenue Growth (%) 15.90
UTMD's Revenue Growth (%) is ranked higher than
89% of the 248 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. UTMD: 15.90 )
UTMD' s 10-Year Revenue Growth (%) Range
Min: -8.7   Max: 16.5
Current: 15.9

-8.7
16.5
EBITDA Growth (%) 21.90
UTMD's EBITDA Growth (%) is ranked higher than
91% of the 210 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.40 vs. UTMD: 21.90 )
UTMD' s 10-Year EBITDA Growth (%) Range
Min: -8.4   Max: 30.9
Current: 21.9

-8.4
30.9
EPS Growth (%) 22.30
UTMD's EPS Growth (%) is ranked higher than
89% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. UTMD: 22.30 )
UTMD' s 10-Year EPS Growth (%) Range
Min: -10.4   Max: 24.6
Current: 22.3

-10.4
24.6
» UTMD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

UTMD Guru Trades in Q1 2013

Jim Simons 48,400 sh (New)
Chuck Royce 42,300 sh (unchged)
» More
Q2 2013

UTMD Guru Trades in Q2 2013

Jim Simons 54,700 sh (+13.02%)
Chuck Royce 42,300 sh (unchged)
» More
Q3 2013

UTMD Guru Trades in Q3 2013

Jim Simons 68,100 sh (+24.5%)
Chuck Royce 42,300 sh (unchged)
» More
Q4 2013

UTMD Guru Trades in Q4 2013

Jim Simons 75,400 sh (+10.72%)
Chuck Royce 42,300 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with UTMD



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 17.30
UTMD's P/E(ttm) is ranked higher than
85% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.10 vs. UTMD: 17.30 )
UTMD' s 10-Year P/E(ttm) Range
Min: 3.5   Max: 21.38
Current: 17.3

3.5
21.38
P/B 3.30
UTMD's P/B is ranked higher than
55% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. UTMD: 3.30 )
UTMD' s 10-Year P/B Range
Min: 1.9   Max: 5.58
Current: 3.3

1.9
5.58
P/S 4.89
UTMD's P/S is ranked lower than
73% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.60 vs. UTMD: 4.89 )
UTMD' s 10-Year P/S Range
Min: 2.56   Max: 5.46
Current: 4.89

2.56
5.46
PFCF 16.50
UTMD's PFCF is ranked higher than
87% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.00 vs. UTMD: 16.50 )
UTMD' s 10-Year PFCF Range
Min: 2.96   Max: 25.57
Current: 16.5

2.96
25.57
EV-to-EBIT 12.80
UTMD's EV-to-EBIT is ranked higher than
81% of the 247 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.32 vs. UTMD: 12.80 )
UTMD' s 10-Year EV-to-EBIT Range
Min: 5.8   Max: 14.6
Current: 12.8

5.8
14.6
PEG 0.90
UTMD's PEG is ranked higher than
91% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.13 vs. UTMD: 0.90 )
UTMD' s 10-Year PEG Range
Min: 0.37   Max: 11.73
Current: 0.9

0.37
11.73
Shiller P/E 23.10
UTMD's Shiller P/E is ranked higher than
77% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.28 vs. UTMD: 23.10 )
UTMD' s 10-Year Shiller P/E Range
Min: 8.34   Max: 26.71
Current: 23.1

8.34
26.71

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.89
UTMD's Dividend Yield is ranked higher than
63% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. UTMD: 1.89 )
UTMD' s 10-Year Dividend Yield Range
Min: 0.56   Max: 4.23
Current: 1.89

0.56
4.23
Dividend Payout 0.33
UTMD's Dividend Payout is ranked higher than
66% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.33 vs. UTMD: 0.33 )
UTMD' s 10-Year Dividend Payout Range
Min: 0.21   Max: 0.49
Current: 0.33

0.21
0.49
Dividend growth (3y) 11.80
UTMD's Dividend growth (3y) is ranked higher than
84% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.00 vs. UTMD: 11.80 )
UTMD' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 25.3
Current: 11.8

0
25.3
Yield on cost (5-Year) 3.14
UTMD's Yield on cost (5-Year) is ranked higher than
76% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. UTMD: 3.14 )
UTMD' s 10-Year Yield on cost (5-Year) Range
Min: 0.93   Max: 7
Current: 3.14

0.93
7
Share Buyback Rate -1.20
UTMD's Share Buyback Rate is ranked higher than
78% of the 218 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.70 vs. UTMD: -1.20 )
UTMD' s 10-Year Share Buyback Rate Range
Min: 14.4   Max: -1.2
Current: -1.2

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 15.70
UTMD's Price/Tangible Book is ranked lower than
82% of the 232 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. UTMD: 15.70 )
UTMD' s 10-Year Price/Tangible Book Range
Min: 2.88   Max: 133.52
Current: 15.7

2.88
133.52
Price/DCF (Projected) 1.10
UTMD's Price/DCF (Projected) is ranked higher than
84% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. UTMD: 1.10 )
UTMD' s 10-Year Price/DCF (Projected) Range
Min: 0.5   Max: 1.15
Current: 1.1

0.5
1.15
Price/Median PS Value 1.20
UTMD's Price/Median PS Value is ranked higher than
54% of the 268 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. UTMD: 1.20 )
UTMD' s 10-Year Price/Median PS Value Range
Min: 0.4   Max: 1.33
Current: 1.2

0.4
1.33
Price/Peter Lynch Fair Value 1.00
UTMD's Price/Peter Lynch Fair Value is ranked higher than
89% of the 76 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.90 vs. UTMD: 1.00 )
UTMD' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.44   Max: 3.26
Current: 1

0.44
3.26
Price/Graham Number 3.50
UTMD's Price/Graham Number is ranked lower than
68% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. UTMD: 3.50 )
UTMD' s 10-Year Price/Graham Number Range
Min: 1.14   Max: 8.81
Current: 3.5

1.14
8.81
Earnings Yield (Greenblatt) 7.80
UTMD's Earnings Yield (Greenblatt) is ranked higher than
82% of the 226 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. UTMD: 7.80 )
UTMD' s 10-Year Earnings Yield (Greenblatt) Range
Min: 6.9   Max: 17.4
Current: 7.8

6.9
17.4
Forward Rate of Return (Yacktman) 20.92
UTMD's Forward Rate of Return (Yacktman) is ranked higher than
94% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. UTMD: 20.92 )
UTMD' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 3   Max: 24.7
Current: 20.92

3
24.7

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Utah Medical Products, Inc. was formed as a Utah corporation in 1978. The Company is in the business of producing high quality cost-effective medical devices that are predominantly proprietary, disposable and for hospital use. The Company's range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians' offices. Products are sold in both domestic U.S. and international markets. The Company with particular interest in healthcare for women and their babies, develops, manufactures, assembles and markets a range of well- established disposable and reusable specialty medical devices designed for better health outcomes for patients and their care-providers. It produces innovative medical devices for Blood Pressure Monitoring and Blood Collection, Electrosurgery, Gynecology, Neonatal Critical Care, Perinatology and Urology. The Company's VAD Systems include CMI patented soft silicone bell-shaped birthing cups and patented hand-held vacuum pumps. AROM-COT is a finger cover with a patented prong design to rupture maternal membranes with less patient pain and anxiety. The DISPOSA-HOOD is an infant respiratory hood that is used in the NICU to administer oxygen to neonates and flush CO2 (carbon dioxide) while maintaining a neutral thermal environment critical to proper physiologic responses. The Company's DELTRAN blood pressure monitoring system has been adapted specifically for use in the NICU. The streamlined version eliminates needles used for blood sampling, avoids the loss of scarce neonatal blood volume and provides a closed system that reduces the risk of infection. The LETZ System (loop excision of the transformation zone) is used to excise cervical intraepithelial neoplasia (CIN) and other lower genital tract lesions related to human papilloma virus (HPV) infections. The Company's LETZ System includes patented disposable electrodes, the patented FINESSE electrosurgical generator, and other miscellaneous components. EPITOME is a patented electrosurgical scalpel which delivers precise performance in incision and excision with hemostasis while minimizing thermal side effects. LIBERTY is a device for the conservative treatment and effective control of urinary incontinence in women. LIBERTY is the easiest-to-use, most cost effective incontinence treatment available that yields a therapeutic effect, not just a cover-up. LIBERTY consists of a battery operated electrical stimulation unit and an intravaginal electrode probe. In pressure monitoring, a transducer is used to convert physiological (mechanical) pressure into an electrical signal that is displayed on electronic monitoring equipment. It developed, patented and is now distributing its disposable transducer as a stand alone product, and as a component in sterile blood pressure monitoring kits through direct representatives and other medical companies in the U.S., as well as independent dis

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide